icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
Elsulfavirine as Compared to Efavirenz in
Combination with TDF/FTC: 48-week Study
  Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
R.L. Murphy1, A.V. Kravchenko2 , E.A. Orlova-Morozova3 , F.I. Nagimova4 , O.A. Kozirev5, T.E. Shimonova6 , M.O. Deulina2, N.V. Vostokova7 , O.V. Zozulya7, V.V. Bichko8 1. Northwestern University, Chicago, IL, 2. Russia AIDS Federal Center, Moscow, Russia, 3. Moscow region AIDS Center, Moscow, Russia, 4. Republic Tatarstan AIDS Center, Kazan, Russia, 2. 5. Volgograd region AIDS Center, Volgograd, Russia, 6. Moscow city AIDS Center, Moscow, Russia, 7. IPHARMA, Moscow, Russia, 8. Viriom Inc., San Diego, CA
Pharmacokinetics of VM-1500 20 mg and 40 mg in Healthy and HIV-Infected Patients http://www.natap.org/2014/IAC/IAC_108.htm